Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Post-Vaccination Neutralization Responses to Omicron Sub-Variants
Henning Jacobsen, Maeva Katzmarzyk, Melissa M. Higdon, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1757-1757
Open Access | Times Cited: 21

Showing 21 citing articles:

Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization
Daniel R. Feikin, Melissa M. Higdon, Nick Andrews, et al.
Vaccine (2023) Vol. 41, Iss. 14, pp. 2329-2338
Open Access | Times Cited: 29
Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2
Henning Jacobsen, Ioannis Sitaras, Maeva Katzmarzyk, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 16
Next generation sequencing of multiple SARS-CoV-2 infections in the Omicron Era
Marzia Cavalli, Giulia Campoli, Anna Anselmo, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Isolation and structure elucidation of Dm-CVNH, a new cyanovirin-N homolog with activity against SARS-CoV-2 and HIV-1
Maria Orfanoudaki, Lauren R. H. Krumpe, Shilpa R. Shenoy, et al.
Journal of Biological Chemistry (2025), pp. 108319-108319
Open Access
The Third Dose of BNT162b2 COVID-19 Vaccine Does Not “Boost” Disease Flares and Adverse Events in Patients with Rheumatoid Arthritis
Andrea Picchianti Diamanti, Assunta Navarra, Gilda Cuzzi, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 687-687
Open Access | Times Cited: 8
Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera
Maeva Katzmarzyk, Denise Christine Clesle, Joop van den Heuvel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
COVID-19 Vaccine Effectiveness Studies against Symptomatic and Severe Outcomes during the Omicron Period in Four Countries in the Eastern Mediterranean Region
Manuela Runge, Zahra Karimian, Mehrnaz Kheirandish, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 906-906
Open Access | Times Cited: 1
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
Marjan Meurisse, Lucy Catteau, Joris Adriaan Frank van Loenhout, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 378-378
Open Access | Times Cited: 3
Neutralizing Antibodies against SARS-CoV-2 Beta and Omicron Variants Inhibition Comparison after BNT162b2 mRNA Booster Doses with a New PETIA sVNT Assay
Marta Fogolari, Bruno Daniele Leoni, Marina De Cesaris, et al.
Diagnostics (2023) Vol. 13, Iss. 5, pp. 889-889
Open Access | Times Cited: 2
A machine learning model for predicting serum neutralizing activity against Omicron SARS‐CoV‐2 BA.2 and BA.4/5 sublineages in the general population
Jorge Camacho, Eliseo Albert, Beatriz Álvarez‐Rodríguez, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Open Access | Times Cited: 2
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18–55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial
Keith J. Chappell, Francesca L. Mordant, Alberto A. Amarilla, et al.
EBioMedicine (2023) Vol. 97, pp. 104842-104842
Open Access | Times Cited: 2
Different variants of SARS-CoV-2
Arijit Samanta, Md. Samim Hassan, Taslima Nasrin, et al.
Elsevier eBooks (2024), pp. 13-25
Closed Access
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants
Kristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Epidemiological Features of the COVID-19 and Characteristics of Patients during the Spread of the Omicron SARS-COV-2 in Russia
A. A. Fomicheva, Nikolay Pimenov, S. V. Komarova, et al.
Epidemiology and Vaccinal Prevention (2024) Vol. 23, Iss. 4, pp. 116-127
Open Access
Evaluating the Quality of Studies Assessing COVID-19 Vaccine Neutralizing Antibody Immunogenicity
Maeva Katzmarzyk, Robert Naughton, Ioannis Sitaras, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1238-1238
Open Access
Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study — Yunnan Province, China, 2021–2022
Haitao Yang, Xing Meng, Tingyu Zhuang, et al.
China CDC Weekly (2023) Vol. 5, Iss. 6, pp. 125-130
Open Access | Times Cited: 1
Waning of post-vaccination neutralizing antibody responses against SARS-CoV-2, a systematic literature review and meta-analysis
Henning Jacobsen, Ioannis Sitaras, Maeva Katzmarzyk, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Systematical assessment of the impact of single spike mutations of SARS-CoV-2 Omicron sub-variants on the neutralization capacity of post-vaccination sera
Maeva Katzmarzyk, Denise Christine Clesle, Joop van den Heuvel, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
The Re-Emergence of COVID-19 in 2022 Has Affected People’s Views on Vaccines
Yufei Wu, Huanjie Li, Yunshan Wang
Vaccines (2022) Vol. 10, Iss. 11, pp. 1974-1974
Open Access | Times Cited: 1
Changes in spike protein antibody titer over 90 days after the second dose of SARS-CoV-2 vaccine in Japanese dialysis patients
Haruki Wakai, Natsumi Abe, Touno Tokuda, et al.
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access
Long-term immune protection against SARS-CoV-2 escape variants upon a single vaccination with murine cytomegalovirus expressing the spike protein
Kristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top